May 20, 2026

How to Test for Celiac Disease: Blood Tests, Genetics, and Biopsy Explained

The standard celiac testing pathway (tTG-IgA blood test, total IgA, anti-endomysial antibodies, deamidated gliadin peptide) plus when HLA DQ2/DQ8 genetic testing and duodenal biopsy add value. Includes why you must be eating gluten before testing, common false negatives, and the celiac vs non-celiac gluten sensitivity distinction.

Quick Summary

The standard initial celiac screening test is the tissue transglutaminase IgA antibody (tTG-IgA), almost always paired with a total IgA measurement to rule out IgA deficiency (which can produce false negatives). If those results are positive or borderline, the next steps include confirmatory antibodies (endomysial antibodies or deamidated gliadin peptide) and often a duodenal biopsy for definitive diagnosis. HLA DQ2 and DQ8 genetic testing is useful in a narrow set of scenarios: ruling out celiac in ambiguous cases or evaluating family members. Crucially, all antibody tests require you to be actively eating gluten at the time of testing. Removing gluten before testing causes false negatives within weeks.

You have GI symptoms, fatigue, brain fog, unexplained anemia, or a relative just got diagnosed with celiac disease. You search for a celiac test and find a confusing menu: tTG-IgA, total IgA, EMA, DGP-IgG, HLA DQ2/DQ8, biopsy. Then you read that you have to be eating gluten for the test to work, which feels backwards if you have already started avoiding gluten because it was making you sick.

Here is the part that surprises most people. Celiac disease is not a food allergy or food sensitivity. It is an autoimmune disease in which gluten triggers your immune system to attack your own small intestine. The damage produces a specific antibody signature (tissue transglutaminase IgA) that the standard blood test detects with high accuracy, but only while gluten is being eaten. If you have been gluten-free for weeks, the antibodies fade and the test misses the diagnosis.

This guide walks through every test in the standard celiac workup, when each one is the right choice, why the gluten-before-testing rule matters, what HLA genetic testing actually does, and how to handle ambiguous results.

Celiac Disease Is an Autoimmune Disease, Not an Allergy

The distinction matters because it dictates the right testing approach.

In celiac disease, gluten (specifically the gliadin protein in wheat, barley, and rye) triggers your immune system to produce IgA antibodies against tissue transglutaminase, an enzyme in your gut lining. The resulting inflammation damages the villi of the small intestine, causing malabsorption, anemia, GI symptoms, and a cascade of secondary problems.

A 2017 JAMA review of celiac disease and non-celiac gluten sensitivity emphasized that celiac is a distinct, well-defined autoimmune disease with specific genetic risk markers (HLA DQ2 and DQ8), distinct antibody signatures, and characteristic small bowel histology [1].

This is fundamentally different from:

• IgE-mediated wheat allergy (immediate hypersensitivity)
• Non-celiac gluten sensitivity (gluten-related symptoms without celiac autoimmunity or wheat IgE)
• Wheat intolerance (often FODMAP-driven rather than gluten-driven)

Standard celiac tests do NOT detect IgE wheat allergy or non-celiac gluten sensitivity. Those require different approaches.

The Standard Celiac Testing Sequence

Step 1: tTG-IgA + Total IgA

The first-line test pair, recommended by all major gastroenterology societies:

tTG-IgA (tissue transglutaminase IgA antibody): highly sensitive and specific for celiac disease when patient is on a gluten-containing diet. Sensitivity around 95 percent, specificity around 95 percent in adults with active disease [2].

Total IgA: 2 to 3 percent of celiac patients have IgA deficiency, which produces a false-negative tTG-IgA result. Always measure total IgA at the same time. If IgA deficient, switch to IgG-based tests (tTG-IgG, DGP-IgG).

How to interpret:

• Both negative + normal IgA + clinical suspicion low: celiac unlikely; consider other diagnoses
• tTG-IgA positive + normal IgA: high probability of celiac; proceed to confirmatory testing
• tTG-IgA negative + low IgA: switch to IgG-based testing
• tTG-IgA equivocal: repeat or proceed to confirmatory testing

A 2025 study in Pediatrics specifically examined positive predictive value of tTG-IgA across thresholds and confirmed that very high titers (more than 10× the upper limit of normal) have positive predictive value approaching 100 percent in pediatric populations [3].

Step 2: Confirmatory Antibody Tests

If tTG-IgA is positive or equivocal, the next-tier tests improve specificity:

Endomysial Antibody (EMA-IgA): highly specific (close to 100 percent) but less sensitive than tTG-IgA. Used to confirm a positive tTG-IgA.

Deamidated Gliadin Peptide (DGP-IgA and DGP-IgG): useful when IgA-deficient (DGP-IgG performs better than tTG-IgG in this group).

Step 3: Duodenal Biopsy (Histology)

The traditional gold standard. Multiple biopsy samples are taken from the small intestine during endoscopy and graded for villous atrophy (Marsh classification).

Strengths:

• Definitive diagnosis
• Quantifies severity of intestinal damage
• Can detect celiac even when antibody tests are ambiguous

Limitations:

• Invasive (requires endoscopy under sedation)
• Patchy disease can be missed if not enough samples taken
• Required to be on gluten-containing diet at time of biopsy (otherwise villi may have healed)

A 2025 European Society for the Study of Coeliac Disease guideline confirmed that biopsy remains required for most adult diagnoses, though selected pediatric cases with very high tTG-IgA + positive EMA + positive HLA + clear symptoms can be diagnosed without biopsy [4].

A 2019 AGA Clinical Practice Update emphasized that biopsy interpretation requires experienced pathologist review and adequate sampling (4 to 6 biopsies including the duodenal bulb) [5].

Step 4: HLA DQ2 and DQ8 Genetic Testing (Selective Use)

About 99 percent of people with celiac disease carry HLA DQ2 or DQ8 alleles. About 30 to 40 percent of the general population also carry these alleles without ever developing celiac. This makes HLA testing useful for ruling celiac OUT but not for ruling it IN.

When HLA testing is genuinely useful:

• Ambiguous serology + clinical history
• Patient already on a gluten-free diet who cannot tolerate a gluten challenge for serology re-testing
• First-degree relatives of someone with confirmed celiac (negative HLA rules out lifetime risk)
• Pediatric “no-biopsy” diagnosis pathway (alongside high tTG-IgA + positive EMA)

A 2019 American Journal of Gastroenterology clinician’s guide to HLA genetics in celiac covered the appropriate indications and emphasized that HLA testing is not first-line screening [6].

Why You MUST Be Eating Gluten Before Testing

This is the most important practical point.

Celiac antibody tests detect the immune response to active gluten exposure. Once you remove gluten, your immune system stops producing those antibodies. Levels begin to decline within weeks and most patients become seronegative within 6 to 12 months of strict gluten-free eating.

If you have been gluten-free for more than 4 to 6 weeks, your tTG-IgA test may be falsely negative even if you have active celiac.

The gluten challenge protocol for someone already off gluten who wants to test:

• Reintroduce gluten for at least 6 weeks (some guidelines say 8 to 12 weeks)
• Aim for at least 3 grams of gluten per day (roughly 2 slices of wheat bread)
• Then test

For many patients this is the cruelest part of the diagnostic journey. They started feeling better off gluten, and the cost of confirming celiac (definitively) is eating it again for weeks while symptoms return.

For people unwilling or unable to do a gluten challenge:

• HLA DQ2/DQ8 negative essentially rules out celiac (no need to challenge)
• HLA positive + symptoms + clinical context may justify treating as celiac without definitive serology

Common False Negatives

Beyond the gluten-avoidance issue:

• IgA deficiency (2 to 3 percent of celiac patients): always check total IgA
• Early disease or mild presentation: antibodies may not yet be elevated
• Atypical presentations: A 2012 Gastroenterology Research and Practice study documented that adults with atypical presentations (no GI symptoms, presenting with anemia, osteoporosis, or neurological symptoms) often have lower tTG-IgA titers than classical-presentation patients [7]
• Pediatric vs adult differences: children often have higher antibody titers; adults may be more borderline
• Recent immunosuppression: drugs that suppress B-cell function can reduce antibody production

Who Should Get Tested for Celiac

High-priority groups:

• Chronic GI symptoms (diarrhea, bloating, abdominal pain) not explained by other conditions
• Iron-deficiency anemia not responsive to supplementation
• Unexplained weight loss
• Chronic fatigue with no other explanation
• Recurrent oral aphthous ulcers
• Dermatitis herpetiformis (skin manifestation of celiac)
• Osteoporosis or osteopenia at unexpectedly young age
• Unexplained elevated liver enzymes
• First-degree relatives of confirmed celiac patients (lifetime risk approximately 10 percent)
• Type 1 diabetes, autoimmune thyroid disease, or other autoimmune conditions (celiac coexists at higher rates)

A 2025 study in Revista Espanola de Enfermedades Digestivas documented atypical celiac presentations including hemorrhagic shock, emphasizing the importance of testing in unexplained clinical pictures [8].

Non-Celiac Gluten Sensitivity (NCGS) Is Different

Some people experience symptoms after eating gluten but test negative for both celiac and IgE-mediated wheat allergy. This is called non-celiac gluten sensitivity (NCGS).

The 2017 JAMA review covered NCGS and noted that:

• The diagnosis is one of exclusion (rule out celiac and wheat allergy first)
• The mechanism is not yet well understood (possibly amylase-trypsin inhibitors, FODMAPs, or other wheat components rather than gluten itself)
• Symptom relief on a gluten-free diet does not confirm NCGS; placebo effects and broader dietary changes can produce the same outcome [1]

If celiac and wheat allergy are both ruled out and you still feel better gluten-free, the practical approach is to continue avoiding it without insisting on a specific diagnosis label.

Test This with Mito

Mito Health offers a celiac disease blood test alongside the broader biomarker panels that contextualize celiac-associated symptoms:

• Celiac Disease Screen: tTG-IgA-based blood test for celiac autoimmunity. The right starting test if you have GI symptoms, unexplained anemia, or a first-degree relative with celiac. Available at $99.
• Mito Core Panel: 100+ biomarkers including ferritin (celiac often causes iron-deficiency anemia), liver enzymes (celiac can elevate these), vitamin D, and other markers commonly abnormal in untreated celiac. Individual testing starts at $349, duo testing at $668.
• Gut Microbiome Test: celiac disease alters the gut microbiome; useful when celiac is confirmed and you want to monitor recovery alongside the gluten-free diet.
• Food Allergy Profile: if there is suspicion of concurrent IgE wheat allergy (rare but distinct from celiac).
• Build Your Own panel: combine celiac screening with ferritin, vitamin D, and liver enzymes for the typical celiac-associated marker pattern. Pricing starts at $40 per marker.
• How Mito testing works: walks through sample collection, turnaround, and how the physician-guided interpretation report is delivered.

How to decide which panel fits your situation:

• Currently eating gluten, want a screen: Celiac Disease Screen. tTG-IgA is the right starting point.
• Already off gluten for weeks, considering testing: consider HLA DQ2/DQ8 genetic testing (rules celiac out if negative; if positive, you would need a gluten challenge before tTG-IgA testing).
• GI symptoms with no obvious cause: Mito Core Panel + Celiac Disease Screen together. Many celiac-relevant markers (ferritin, liver enzymes, vitamin D) are in the core panel.
• First-degree relative just diagnosed: Celiac Disease Screen. Lifetime risk is approximately 10 percent.

If your tTG-IgA is positive or borderline, see a gastroenterologist for confirmatory antibody testing and consideration of duodenal biopsy. Consumer testing alone is not sufficient for definitive celiac diagnosis.

Key Takeaways

• Celiac disease is an autoimmune disease triggered by gluten, distinct from wheat allergy and non-celiac gluten sensitivity.
• The standard first-line test is tTG-IgA paired with total IgA (to rule out IgA deficiency).
• Confirmatory antibody tests include EMA-IgA and DGP-IgA or DGP-IgG.
• Duodenal biopsy remains the diagnostic gold standard for adults, though selected pediatric cases can be diagnosed without biopsy if antibody titers are very high.
• HLA DQ2/DQ8 genetic testing is best used to rule celiac OUT, not to rule it IN.
• All antibody tests require active gluten consumption at time of testing. Off-gluten for 4+ weeks causes false negatives.
• A gluten challenge (6 to 12 weeks of gluten reintroduction) is required if you are already gluten-free and want to test.
• High-priority testing groups include chronic GI symptoms, unexplained anemia, family history of celiac, and other autoimmune conditions.
• Non-celiac gluten sensitivity is real but a diagnosis of exclusion; it is not detected by celiac tests.

Medical Disclaimer

This guide is for educational purposes and does not replace evaluation by a qualified healthcare professional. Celiac disease is a chronic condition with serious complications if untreated, including malnutrition, osteoporosis, infertility, and increased risk of certain cancers. If you have a positive celiac screen or strong clinical suspicion, see a gastroenterologist for confirmatory testing before starting or stopping a gluten-free diet.

Track Your Progress

Celiac disease is most informative when paired with markers commonly abnormal in untreated celiac:

• hsCRP for systemic inflammation
• How to Improve Your hsCRP Naturally for inflammation context

Related Content

• How a Gut Microbiome Test Works for the gut health follow-up after celiac diagnosis
• Understanding Autoimmune Markers for the broader autoimmune workup that often overlaps with celiac
• How to Test for Food Allergies for the distinct wheat allergy workup that is sometimes confused with celiac

References

1. Lebwohl B, Sanders DS, Green PHR. Celiac Disease and Nonceliac Gluten Sensitivity: A Review. JAMA. 2017. PMID 28810029.
2. Niewinski MM. Celiac disease: a review. World J Gastroenterol. 2006. PMID 17075969.
3. Positive Predictive Value of Tissue Transglutaminase IgA for Celiac Disease. Pediatrics. 2025. PMID 40774665.
4. European Society for the Study of Coeliac Disease 2025 Updated Guidelines. United European Gastroenterol J. 2025. PMID 40999951.
5. Husby S et al. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease. Gastroenterology. 2019. PMID 30578783.
6. Brown NK et al. A Clinician’s Guide to Celiac Disease HLA Genetics. Am J Gastroenterol. 2019. PMID 31274511.
7. Frequency of celiac disease in adult patients with typical or atypical presentations. Gastroenterol Res Pract. 2012. PMID 22545042.
8. Celiac disease presenting as hemorrhagic shock: a rare complication. Rev Esp Enferm Dig. 2024. PMID 38205718.